Inventor
WOLIN RONALD L
US52 patents
⚠️ This page may combine multiple inventors who share the name “WOLIN RONALD L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
21 patentsUS5721236AFeb 24, 1998
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP72 citations96
US5719148AFeb 17, 1998
Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
SCHERING CORP92 citations96
US5696121ADec 9, 1997
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP50 citations96
US6365588B1Apr 2, 2002
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP22 citations92
US6242458B1Jun 5, 2001
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP25 citations92
US6100279AAug 8, 2000
Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
SCHERING CORP53 citations92
US6075025AJun 13, 2000
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP34 citations92
US5958939ASep 28, 1999
Tricyclic compounds useful for inhibition of a g-protein function and for treatment of proliferative diseases
SCHERING CORP26 citations92
US5807853ASep 15, 1998
Tricyclic amide and urea compounds, useful inhibition of g-protein function and for treatment of proliferative diseases
SCHERING CORP18 citations92
US5728703AMar 17, 1998
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP34 citations92
US5703090ADec 30, 1997
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP33 citations92
US5684013ANov 4, 1997
Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
SCHERING CORP35 citations92
US7507767B2Mar 24, 2009
Cannabinoid receptor ligands
SCHERING CORP8 citations84
US7067539B2Jun 27, 2006
Cannabinoid receptor ligands
SCHERING CORP18 citations84
US6492381B1Dec 10, 2002
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP7 citations74
US6440989B2Aug 27, 2002
Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
SCHERING CORP7 citations74
US6218401B1Apr 17, 2001
Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
SCHERING CORP10 citations74
US6300338B1Oct 9, 2001
Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
SCHERING CORP1 citations63
US6130229AOct 10, 2000
Tricyclic compounds having activity as RAS-FPT inhibitors
SCHERING CORP3 citations63
US7718702B2May 18, 2010
Cannabinoid receptor ligands
SCHERING CORP5 citations62
US5977128ANov 2, 1999
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP2 citations62
JANSSEN PHARMACEUTICA NV
19 patentsUS9290476B2Mar 22, 2016
Methylene linked quinolinyl modulators of RORγt
JANSSEN PHARMACEUTICA NV31 citations93
US9221804B2Dec 29, 2015
Secondary alcohol quinolinyl modulators of RORγt
JANSSEN PHARMACEUTICA NV35 citations93
US9309222B2Apr 12, 2016
Phenyl linked quinolinyl modulators of RORγt
JANSSEN PHARMACEUTICA NV13 citations82
US9403816B2Aug 2, 2016
Phenyl linked quinolinyl modulators of RORγt
JANSSEN PHARMACEUTICA NV3 citations73
US9346782B2May 24, 2016
Alkyl linked quinolinyl modulators of RORγt
JANSSEN PHARMACEUTICA NV3 citations73
US9328095B2May 3, 2016
Heteroaryl linked quinolinyl modulators of RORgammat
JANSSEN PHARMACEUTICA NV3 citations73
US10369146B2Aug 6, 2019
Phenyl linked quinolinyl modulators of RORγt
JANSSEN PHARMACEUTICA NV5 citations72
US9624225B2Apr 18, 2017
Quinolinyl modulators of RORγt
JANSSEN PHARMACEUTICA NV3 citations72
US9303015B2Apr 5, 2016
Heteroaryl linked quinolinyl modulators of RORγt
JANSSEN PHARMACEUTICA NV4 citations72
US9284308B2Mar 15, 2016
Methylene linked quinolinyl modulators of RORγt
JANSSEN PHARMACEUTICA NV6 citations71
US11254673B2Feb 22, 2022
Small molecule inhibitors of NF-κB inducing kinase
JANSSEN PHARMACEUTICA NV2 citations69
US11827634B2Nov 28, 2023
Small molecule inhibitors of NF-kB inducing kinase
JANSSEN PHARMACEUTICA NV0 citations60
US10201546B2Feb 12, 2019
Quinolinyl modulators of RORγt
JANSSEN PHARMACEUTICA NV0 citations51
US8686142B2Apr 1, 2014
2-aminopyrimidine modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV0 citations51
US7915420B2Mar 29, 2011
Aryl piperidine amides
JANSSEN PHARMACEUTICA NV0 citations51
US10975037B2Apr 13, 2021
Phenyl substituted pyrazoles as modulators of RORγt
JANSSEN PHARMACEUTICA NV0 citations49
US9732087B2Aug 15, 2017
Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV0 citations49
US11034658B2Jun 15, 2021
Pyridinyl pyrazoles as modulators of RORγT
JANSSEN PHARMACEUTICA NV0 citations48
US7754882B2Jul 13, 2010
Hexahydro-pyrrolo-isoquinoline compounds
JANSSEN PHARMACEUTICA NV0 citations48
ORTHO MCNEIL PHARM INC
3 patents(unassigned)
2 patentsBREITENBUCHER J GUY
2 patentsCAI HUI
1 patentJANSSEN PHARACEUTICA NV
1 patentAPODACA RICHARD
1 patentShowing the top 50 of 52 patents by PatentIndex Score.